Cell Signaling Technology

Phospho-PKC zeta (Thr410)/lambda (Thr412) (F2E5C) Rabbit Monoclonal Antibody

#32450 · $176

5
Citing papers
157
Combined citations
Supplier page Find this product

Research areas

Nanoplatforms for cancer theranostics2CAR-T cell therapy research2Cancer, Hypoxia, and Metabolism1Cancer-related Molecular Pathways1Immunotherapy and Immune Responses1Mesenchymal stem cell research1Microtubule and mitosis dynamics1Nanocluster Synthesis and Applications1

Papers citing this product

1
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
Proceedings of the National Academy of Sciences·2017·146 cit.·DOI
2
Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway
Oncotarget·2020·7 cit.·DOI
3
Synergistic ROS Generation via Core–Shell Nanostructures with Increased Lattice Microstrain Combined with Single-Atom Catalysis for Enhanced Tumor Suppression
ACS Applied Materials & Interfaces·2024·3 cit.·DOI
4
Involvement of MEK, ERK, PKC and GSK3B in Maintaining the Mitotic Spindle
International Journal of Biology·2013·1 cit.·DOI
5
Protective effects of MSC-conditioned medium on DFO-induced mimetic-hypoxia injury of renal tubular epithelial cells
Research Square·2022·DOI

Similar products

ProductVendorPricePapers
Phospho-PKC zeta (Thr410)/lambda (Thr412) AntibodyRabbitCell Signaling Technology$148100
Phospho-PKC zeta (Thr410)/lambda (Thr412) (F2E5C) Rabbit Monoclonal Antibody — Evidence — PubIndex